01—History
Long-Term Debt History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- $42.85B
1 older move runs past ±150% (largest +668.5%); point at, tap or drag across the bars to read one.
02—Ledger
Long-Term Debt, period by period
| Period | Scale | Value | Change | Source |
|---|---|---|---|---|
| FY2025 | $42.85B | −10.0% | 10-K | |
| FY2024 | $47.60B | +29.9% | 10-K | |
| FY2023 | $36.65B | +4.6% | 10-K | |
| FY2022 | $35.06B | −11.5% | 10-K | |
| FY2021 | $39.60B | −18.1% | 10-K | |
| FY2020 | $48.34B | +11.4% | 10-K | |
| FY2019 | $43.39B | +668.5% | 10-K | |
| FY2018 | $5.65B | −19.1% | 10-K | |
| FY2017 | $6.97B | +22.0% | 10-K | |
| FY2016 | $5.72B | −12.7% | 10-K | |
| FY2015 | $6.55B | −9.6% | 10-K | |
| FY2014 | $7.24B | −9.3% | 10-K | |
| FY2013 | $7.98B | +21.5% | 10-K | |
| FY2012 | $6.57B | +22.2% | 10-K | |
| FY2011 | $5.38B | +0.9% | 10-K | |
| FY2010 | $5.33B | −13.1% | 10-K | |
| FY2009 | $6.13B | −6.9% | 10-K | |
| FY2008 | $6.58B | — | 10-K |
03—Questions
What is long-term debt?
Long-term debt includes bonds, mortgages, and other borrowings with maturities greater than one year.
What is BRISTOL MYERS SQUIBB CO's current long-term debt?
BRISTOL MYERS SQUIBB CO (BMY) annual long-term debt for 2025 was $42.85B, a 9.98% decline from 2024. BRISTOL MYERS SQUIBB CO long-term debt for the quarter ending March 31, 2026 was $42.15B.
What was BRISTOL MYERS SQUIBB CO's long-term debt in 2024?
BRISTOL MYERS SQUIBB CO annual long-term debt for 2024 was $47.60B, a 29.87% increase from 2023.
What was BRISTOL MYERS SQUIBB CO's long-term debt in 2023?
BRISTOL MYERS SQUIBB CO annual long-term debt for 2023 was $36.65B, a 4.56% increase from 2022.
What is BRISTOL MYERS SQUIBB CO's 5-year long-term debt CAGR?
BRISTOL MYERS SQUIBB CO long-term debt grew at a compound annual growth rate (CAGR) of 2.38% from FY2020 to FY2025, going from $48.34B to $42.85B over 5 years.
- Company
- BRISTOL MYERS SQUIBB CO
- Ticker
- BMY
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations